VRAX (Virax Biolabs Group Limited Ordinary Shares) Stock Analysis - SEC Filings

Virax Biolabs Group Limited Ordinary Shares (VRAX) is a publicly traded Healthcare sector company. As of May 21, 2026, VRAX trades at $0.29 with a market cap of $1.74M and a P/E ratio of 0.00. VRAX moved +2.30% today. Year to date, VRAX is -16.86%; over the trailing twelve months it is -70.87%. Its 52-week range spans $0.10 to $3.62. Rallies surfaces VRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find VRAX SEC filings?

Rallies organizes VRAX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

VRAX Key Metrics

Key financial metrics for VRAX
MetricValue
Price$0.29
Market Cap$1.74M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$3.62
52-Week Low$0.10
Volume233.88K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest VRAX News

VRAX Analyst Consensus

VRAX analyst coverage data. Average price target: $0.00.

Common questions about VRAX

Where can I find VRAX SEC filings?
Rallies organizes VRAX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show VRAX 10-K and 10-Q filings?
Rallies organizes VRAX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is VRAX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VRAX. It does not provide personalized investment advice.
VRAX

VRAX